Inside Innovation

The University of Washington School of Pharmacy’s Drug Interaction Database has been awarded the Gary Neil Prize for Innovation in Drug Development from the American

A group of cancer research experts are teaming up to launch Affini-T Therapeutics, which aims to develop cancer treatments using T cell receptor (TCR) cancer

Amidst several mergers, acquisitions and funding rounds in the last year, Seattle Inno has named 22 startups to watch in 2022, including Mozart Therapeutics. The

Marc Cummings, former VP of public policy and external affairs at Life Science Washington, has been named President and CEO of the trade association. “It’s

Century Therapeutics and Bristol Myers Squibb (BMS) are collaborating on four programs for hematologic malignancies and tumors. BMS, which has a presence in Seattle, will

Absci, a Washington-based life science company has announced a collaboration with Merck worth up to $610 million in milestone payments and upfront fees. Under the

The University of Washington has officially opened the Center for Medication Development for Substance Use Disorders after raising more than $2 million in funding. Researchers

Good Therapeutics, a Seattle startup, has raised $8 million toward advancing therapeutic proteins aimed at helping cancer patients. With 22 employees total, the company is

After announcing it was raising a $6 million Series A last March, Curi Bio Inc., a Seattle life science startup has closed a $10 million

Since acquiring Celgene and its Seattle operations a couple years ago, Bristol Meyers Squibb (BMS) has been growing its presence in the Seattle area. Now,

Bristol Myers Squibb (BMS), which has several facilities in Washington state, is making significant advancements with Breyanzi, a CD19-directed CAR-T cell therapy as a second

A consortium to begin the development of the next COVID-19 vaccine is underway at The Infections Disease Research Institute (IDRI). The Washington-based non-profit is working